The adverse effects of chemicals exerted via estrogen receptors (ER) and androgen receptors (AR) have been studied extensively in recent years. However, those occurring via thyroid hormone receptors (TR) have not been studied enough. We examined the TR-binding activities of thyronine derivatives and alkylphenol derivatives (bisphenol A, parabens and antioxidants with o-t-butylphenol residue) using a yeast two-hybrid assay. In this assay system, the TR-binding activity of 3,5,3′-triiodo-L-thyronine (T 3 ) was detectable at concentrations as low as 3.0 × 10 -8 M and reached a plateau at 1.0 × 10 -6 M. The concentration of T 3 producing 10% of the activity stimulated at 1.0 × 10 -6 M (10% relative effective concentration, REC 10 ) was 2.1 × 10 -8 M. -4 and 4.8 × 10 -5 M, respectively, whereas t-butylbenzene, isopropylbenzene and the other chemicals tested had no detectable TR-bindng activity. These results suggest that a phenolic hydroxyl group and the ortho-substituents may play important roles in the TR-binding activities of these chemicals. This assay system will be a useful tool for screening the TR-binding activities of chemicals.
Detection of Thyroid Hormone Receptor-Binding Activities of Chemicals Using a Yeast Two-Hybrid Assay
The adverse effects of chemicals exerted via estrogen receptors (ER) and androgen receptors (AR) have been studied extensively in recent years. However, those occurring via thyroid hormone receptors (TR) have not been studied enough. We examined the TR-binding activities of thyronine derivatives and alkylphenol derivatives (bisphenol A, parabens and antioxidants with o-t-butylphenol residue) using a yeast two-hybrid assay. In this assay system, the TR-binding activity of 3,5,3′-triiodo-L-thyronine (T 3 ) was detectable at concentrations as low as 3.0 × 10 -8 M and reached a plateau at 1.0 × 10 -6 M. The concentration of T 3 producing 10% of the activity stimulated at 1.0 × 10 -6 M (10% relative effective concentration, REC 10 -4 and 4.8 × 10 -5 M, respectively, whereas t-butylbenzene, isopropylbenzene and the other chemicals tested had no detectable TR-bindng activity. These results suggest that a phenolic hydroxyl group and the ortho-substituents may play important roles in the TR-binding activities of these chemicals. This assay system will be a useful tool for screening the TR-binding activities of chemicals.
tors. 8) TR is a member of this superfamily as are the receptors for steroid hormones. Thyroid hormone fulfils an important role in the development of neurons, multiplication of cells, cell death and energy metabolism of many organisms. 9) Thus, there may be chemicals which perturb the endocrine system by modulating TR function. For relevant examples, it is doubted that the dioxins and polychlorinated biphenyls (PCBs) produce their adverse effects by disrupting thyroid hormone function directly. 10, 11) Compared to the numerous reports regarding estrogen receptors (ER) [3] [4] [5] and androgen receptors (AR), 2, 6) there are few concerning the biological effects of chemicals that act through thyroid hormone receptors (TR).
As a method for evaluating the thyromimetic activities of chemicals, a frog metamorphosis assay 12) and a thyroid hormone receptor binding assay 10) have been established. We have developed a novel screening method for chemicals with hormonal activities
INTRODUCTION
Since the publication of "Our Stolen Future" 1) in 1996, there has been considerable concern about the disruptive effects of chemicals on the endocrine systems of humans and wild life, especially via the hormone receptors.
2) Chemicals with such effects are referred to as endocrine disruptors (EDs). The effects of chemicals on the function of steroid hormones, especially estrogen and androgen, have been studied extensively. [3] [4] [5] [6] Most of the activity of steroid hormones is mediated through their receptors, which reside in the cell nucleus and regulate the transcription of target genes in a ligand-dependent manner. 7) Nuclear hormone receptors constitute a large superfamily of ligand-inducible transcriptional fac-*To whom correspondence should be addressed: Osaka Prefectural Institute of Public Health, 3-69, 1-chome, Nakamichi, Higashinari-ku, Osaka 537-0025, Japan. Tel.: +81-6-6972-1321; Fax: +81-6-6972-2393; E-mail: ykkitaga@iph.pref.osaka.jp using a yeast two-hybrid system and demonstrated that this method detected the ER-, AR-and TR-binding activities of chemicals. 13) We tested the ER-binding activities of 517 chemicals using the yeast twohybrid assay. 14) In that manuscript, we reported that a phenol with a hydrophobic moiety at the para-position is a key structural motif of ER-binding chemicals. These results were supported by the findings obtained from a crystallographic study of the ligandbinding ER. The study reported that the structural features of 17-β-estradiol (E 2 ), a hydrophobic steroid skeleton with a phenolic hydroxyl group, played a crucial role in the interaction between ER and E 2 . 15) There is a reasonable relationship between the results obtained from the yeast two-hybrid assay and findings from the crystallographic study. Wagner et al. performed crystallographic analysis of TR and its ligands and reported that a phenol group in the ligands also played a key role in activation of the receptor. 16) For designing an iodo-free drug with thyromimetic activity, an o-isopropylphenol residue is useful for optimization of the activity. 17) Hydroxylated PCBs compete with 3,5,3′,5′-tetraiodo-L-thyronine (T 4 ) for the binding to transthyretin to perturb the thyronine hormone homeostasis. 18) Thus, there is relevance to studies of the TR-binding activities of chemicals with a phenol group. There are few reports concerning the thyromimetic activities of chemicals. Here, we examined the TR-binding activities of chemicals with a phenol group, such as alkylphenols, bisphenol A, tetrabromobisphenol A and antioxidants with a t-butylphenol residue, as well as thyronines, by our yeast two-hybrid assay. Fig. 1 . The Yeast Two-Hybrid Assay ---The TR-binding activities of chemicals were examined with a yeast two-hybrid assay system with the thyroid hormone receptor, TRα, and the coactivator, transcriptional intermediary factor 2 (TIF2), as described previously. 13) Minor modifications of the duration of test chemical incubation were made in order to raise the assay sensitivity. The yeast expression plasmids, pGBT9 and pGAD424, were purchased from Clontech (Palo Alto, CA, U.S.A.). The LBD of TRα (codons 173-461) was amplified by reverse transcription (RT)-PCR using total RNA from rat liver. The EcoRI and BamHI sites were introduced in 5′ and 3′ terminus of amplified fragments and subcloned into EcoRI-BamHI sites of pGBT9 so that they were in the same translational reading frame as the vector's GAL4 DNA binding domain (GAL4DBD). The receptor interaction domain (RID) of coactivator, TIF2, was amplified by PCR from cDNAs 19) and subcloned into EcoRI-BamHI-digested pGAD424 for the production of fusion pro- . Yeast cells were transformed with the pGBT9-TRα and pGAD424-TIF2 using lithium acetate method and selected by growth on synthetic dropout (SD) medium (lacking tryptophan and leucine). Yeast transformants were preincubated overnight at 30°C in SD medium free from tryptophan and leucine. The culture (250 µl) was then mixed in a small test tube with a DMSO solution (2.5 µl) of test chemical and incubated for 24 hr at 30°C. After washing by centrifugation, the cells were digested enzymatically by incubation with 1 mg/ml Zymolyase 20T (100 µl) at 37°C for 15 min. The lysate was mixed with 4 mg/ml o-nitrophenyl-β-Dgalactoside (40 µl) and reacted at 30°C until development of the yellow color before the reaction was stopped by the addition of 1 M Na 2 CO 3 (100 µl). β-Galactosidase activity is calculated as described previously and represents the mean ± S.D. of 3 independent experiments performed on separate days. The results were evaluated by relative activity, expressed as 10% relative effective concentration (REC 10 ), that is the concentration of the test chemical showing 10% of the agonist activity of 1.0 × 10 -6 M T 3 , which is the optimum concentration for T 3 . When the activity of test chemical was higher than REC 10 within the concentration tested, we judged the chemical as positive. When it was judged to be negative, the highest dose tested is indicated.
MATERIALS AND METHODS

Chemicals
RESULTS
The β-galactosidase activities induced by T 3 were detectable from 3.0 × 10 -8 M and reached a plateau at 1.0 × 10 -6 M. The β-galactosidase activity obtained by incubation with 1.0 × 10 -6 M T 3 was 1460 ± 60 u (Fig. 2) . REC 10 value of T 3 was 2.1 × 10 -8 M. Except for thyronine, thyronine derivatives T 4 , rT 3 and T 2 , also exhibited TR-binding activities. Their REC 10 values are listed in Table 1 . The maximal activity induced by T 4 reached that of T 3 at 1.0 × 10 -6 M and higher. The activity induced by rT 3 and T 2 reached a plateau from 10 -5 M and 3.0 × 10 -5 M at around 80 and 70% of 1.0 × 10 -6 M T 3 , respectively. Tyrosine and its iodinated derivatives did not exhibit TR-binding activities within their soluble concentration. However, 3.0 × 10 -4 M 3,5-dibromotyrosine exhibited weak TR-binding activity (less than 10% activity of 1.0 × 10 -6 M T 3 ). Among alkylphenols, p-hydroxybenzoates and bisphenol A derivatives were examined, only oisopropylphenol and o-t-butylphenol exhibited TRbinding activities (Fig. 2) . The REC 10 values of oisopropylphenol and o-t-butylphenol were 3.1 × 10 -4 and 4.8 × 10 -5 M, respectively. Cytotoxic effects of these chemicals were observed at 1.0 × 10 -3 M and higher. Other alkylphenols, p-hydroxybenzoates and bisphenol A derivatives did not exhibit TR-binding activities. Isopropylbenzene and t-butylbenzene also did not exhibit TR-binding activities. Chemicals with t-butylphenol residue, which are used as antioxidants commercially were examined and found to be negative in this assay system (Table 1) .
Fig. 2. Dose-Response Curves for the TR-Binding Activities of Thyronine Derivatives, o-Isopropylphenol and o-t-Butylphenol
The points represent averages β-galactosidase activities obtained from three independent experiments on separate days. Bars represent S.D. T 3 (᭺); T 4 (᭹); rT 3 
(᭝); T 2 (ᮀ); o-t-butylphenol (᭡); o-isopropylphenol () ; thyronine (᭞).
DISCUSSION
T 3 and T 4 have agonist activity at TR, whereas rT 3 and T 2 do not. 20) In this study, T 3 , T 4 , rT 3 and T 2 exhibited TR activating ability with the rank order of potency T 3 > T 4 > rT 3 > T 2 . rT 3 and T 2 were partial-agonists at TR in this assay system. The substantial lengths of the TR and TIF2 were fused with 
Thyrosine derivatives Thyrosine
a) The concentration showing 10% activity of 10 −6 M T 3 (relative activity). b) The activity of 1.0 × 10 −3 M L-Thyronine was less than 10% the activity of the 1.0 × 10 −6 M T 3 .
the GAL4 DNA binding domain and activation domain, respectively. The intact TR and TIF2 were not produced in the yeast cells. This background in the assay system could be one reason for our observations.
Drug design studies on iodine-free TR agonists produced the following information: 1) a phenol group is essential for activity; 2) the amino acid residue of T 3 is not necessary; and, 3) 3′-iodine can be replaced by an isopropyl group. 17) By the crystallographic analysis of TR, it was also found that a phenol group in ligands plays an important role in activation of the receptor.
16) Thus, we conducted an examination of the TR-binding activities of alkylphenols, parabens and bisphenol A derivatives. o-Isopropylphenol and o-t-butylphenol exhibited activities. When β-galactosidase was induced by the interaction of these chemicals and the endogenous factor of the yeast, it was assumed that the activities did not occur via TR-TIF2. However, we have confirmed that these chemicals did not exhibit ER-binding activities in the yeast two-hybrid assay with ER-TIF2 (data not shown). Therefore these chemicals actually exert these actions via TR-TIF2. All other alkylphenols examined were negative. The size and position of alkyl group could be a restrictive factor. [4-(4-Hydroxy-3-isopropyl-benzyl)-3,5-dimethylphenoxy]-acetic acid, 17) 3,5-dimethyl-3′-isopropylthyronine 16 ) and 3,5-dibromo-3′-isopropylthyronine 16) were synthesized as iodine-free TR agonists. These chemicals adopted the isopropyl group as a substitute for iodine. In o-isopropylphenol and o-t-butylphenol, the isopropyl group and the t-butyl group seemed to mimic the iodine of the 3′ position of T 3 , respectively. Interestingly, o-iodophenol did not exhibit activity. Iodine is an electron-accepting substituent, whereas the isopropyl and t-butyl groups are electron-donating substituents. The degree of dissociation of phenol may also affect the TR-binding activities of o-alkylphenols.
The phenolic system antioxidants, listed in Table 1 , have an o-t-butylphenol residue in the molecule. These antioxidants are important industrial materials, which are widely used in foods and resins. We also evaluated the TR-binding activities of these antioxidants. No antioxidants exhibited TRbinding activities. Except for BHA and BHT, the structures of antioxidants were larger than those of thyroid hormones and o-t-butylphenol. Steric hindrance may prevent the antioxidants from binding to TR and/or activating it. These antioxidants are decomposed to the smaller molecules with o-tbutylphenol in vivo. 21, 22) Their TR-binding activities could be examined subsequent to this report. Both butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT), derivatives of 2,6-di-tbutylphenol, were negative. The additional substitution at the ortho-position of o-t-butylphenol may reduce the TR-binding activity as 5′-iodine of T 4 reduced the activity of T 3 .
3,5-Dibromo-tyrosine exhibited weak TR-binding activity. This result suggests that chemicals with o-bromophenol residue may affect the activation of TR. Hydroxylated polybrominated biphenyls (PBBs) and tetrabromobisphenol A (TBBPA) compete with T 4 for binding to transthyretin.
23) The study of TRbinding and anti-TR-binding activities of PBBs and polybrominated dipheyl ethers (PBDEs) and their metabolites are ongoing in our laboratory.
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